HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Causal associations between changes in lipid profiles and risk of gallstone disease: a two-sample Mendelian randomization study.

AbstractBackground:
Nonalcoholic fatty liver disease (NAFLD) has been linked to gallstone disease (GSD) in observational studies; however, the relationships between certain lipid profiles and GSD remain unclear.
Methods:
We adopted a two-sample Mendelian randomization (MR) framework by applying different statistical methods to assess causalities between lipid profiles and GSD. We identified single-nucleotide polymorphisms (SNPs) for blood lipids and NAFLD from separate previous genome-wide association studies (GWASs).
Results:
We retrieved GSD SNPs attributed to 10,520 cases and 361,194 controls and validated our estimates using GWAS summary data from UK Biobank. We also performed sex-stratified analyses. Based on the summary estimates of 41, 59, 35, and 2 SNPs for low-density lipoprotein cholesterol (LDLC), high-density lipoprotein cholesterol (HDLC), triglycerides (TGs), and NAFLD, respectively, we found no evidence of a causal relationship between genetically-predicted lipid profiles and GSD. The odds ratios were 0.995 for LDLC [95% confidence interval (CI): 0.994-0.998] per 0.98 mmol/L, 0.999 for HDLC (95% CI: 0.996-1.003) per 0.41 mmol/L, 0.997 for TGs (95% CI: 0.994-1.001) per 1 mmol/L, and 0.993 for NAFLD (95% CI: 0.984-1.003). No evidence of associations between lipid profile s and GSD in validation MR analyses or the sex-stratification analyses was noted.
Conclusions:
Genetically predicted hyperlipidemia or NAFLD is not causally associated with GSD.
AuthorsXiaofeng Yuan, Haitian Chen, Kaining Zeng, Jiaqi Xiao, Jiaqing Liu, Guowang Lin, Jiebin Zhang, Tongyu Lu, Jianye Cai, Jia Yao, Yingcai Zhang, Xin Sui, Jinliang Liang, Jun Zheng
JournalAnnals of translational medicine (Ann Transl Med) Vol. 10 Issue 15 Pg. 818 (Aug 2022) ISSN: 2305-5839 [Print] China
PMID36035003 (Publication Type: Journal Article)
Copyright2022 Annals of Translational Medicine. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: